Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study

DSpace Repository

Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study

Author: Wagner, Nikolaus B.; Lenders, Max M.; Kuehl, Kathrin; Reinhardt, Lydia; Andre, Fiona; Dudda, Milena; Ring, Natalie; Ebel, Chiara; Staeger, Ramon; Zellweger, Caroline; Lang, Roland; Paar, Michael; Gussek, Philipp; Richtig, Georg; Stuermer, Suzan H.; Kimeswenger, Susanne; Oellinger, Angela; Forschner, Andrea; Leiter, Ulrike; Weide, Benjamin; Gassenmaier, Maximilian; Schraag, Amadeus; Klumpp, Bernhard; Hoetzenecker, Wolfram; Berking, Carola; Richtig, Erika; Ziemer, Mirjana; Mangana, Johanna; Terheyden, Patrick; Loquai, Carmen; Nguyen, Van Anh; Gebhardt, Christoffer; Meier, Friedegund; Diem, Stefan; Cozzio, Antonio; Flatz, Lukas; Roecken, Martin; Garbe, Claus; Eigentler, Thomas K.
Tübinger Autor(en):
Wagner, Nikolaus B.
Gassenmaier, Maximilian
Klumpp, Bernhard
Flatz, Lukas
Garbe, Claus
Lenders, Max Matthias
Forschner, Andrea Lydia
Leiter-Stöppke, Ulrike
Weide, Benjamin Matthias
Schraag, Amadeus Dominik
Röcken, Martin
Eigentler, Thomas
Published in: Journal For Immunotherapy of Cancer (2021), Bd. 9, Article e002350
Verlagsangabe: Bmj Publishing Group
Language: English
Full text: http://dx.doi.org/10.1136/jitc-2021-002350
ISSN: 2051-1426
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)